New Hope for GCA: Steroid-Free Relief?

Big news for anyone dealing with giant cell arteritis (GCA): Upadacitinib (Rinvoq) just got FDA-approved as only the second real treatment option since 2017! What’s wild is that it helps almost half of patients stay in remission while cutting down on steroids (which, let’s be real, can be rough). For anyone sensitive to steroid side effects or stuck in a relapse cycle, this could be a total game-changer. Anyone else excited to see more options finally popping up? #GCA #Rinvoq #FDAApproval #HealthNews #AutoimmuneDisease #Health